021-51111890
购物车（）
sales@molnova.cn
Tirzepatide
CAS No. 2023788-19-2
Tirzepatide ( LY3298176 )
产品货号. M29810 CAS No. 2023788-19-2
Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4076 | 有现货 |
|
| 10MG | ￥5843 | 有现货 |
|
| 25MG | ￥8677 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Tirzepatide
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).
-
产品描述Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).(In Vivo):Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.
-
体外实验——
-
体内实验Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.
-
同义词LY3298176
-
通路GPCR/G Protein
-
靶点Glucagon Receptor
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number2023788-19-2
-
分子量4813.45
-
分子式C225H348N48O68
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (10.39 mM)
-
SMILES——
-
化学全称Sequence:Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Frias JP, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet. 2018 Nov 17;392(10160):2180-2193.
产品手册
关联产品
-
Taspoglutide
Taspoglutide 是一种胰高血糖素样肽-1 (GLP-1) 激动剂，用于治疗 2 型糖尿病。
-
Avexitide acetate
Avexitide acetate (exendin 9-39) is a potent glucagon-like peptide 1 receptor (GLP-1R) antagonist for the study of post-obesity hypoglycemia.
-
GLP-1 (9-36) amide
GLP-1(9-36)amide 是胰高血糖素样肽-1 (7-36) amide 的主要代谢产物。GLP-1(9-36)amide 是一种人胰腺 GLP-1 受体的拮抗剂。
